Lobbyist Report for PRICEWATERHOUSECOOPERS

PRICEWATERHOUSECOOPERS

Accounting firm

600 13TH STREET, NW, SUITE 1000 WASHINGTON, DC 20005

USA

Lobbying on the following issues:

ACCOUNTING TAXATION/INTERNAL REVENUE CODE

Support for continued investor protections under Sarbanes-Oxley; Issues impacting the accounting and auditing profession; Independence of accounting standard setting; PCAOB disciplinary proceedings, PCAOB Enforcement Transparency Act of 2019, S. 1256 draft House bill; Implementation of John S. McCain National Defense Authorization Act for Fiscal Year 2019, Public Law 115-222 (provisions related to contractor disclosures); National Defense Authorization Act for Fiscal Year 2020, H.R. 2500; Whistleblower Program at PCAOB, draft House bill

Various issues related to the taxation of pass-through entities; Mobile Workforce State Income Tax Simplification Act, S. 604

Lobbyists:

O'BRIEN, MICHAEL E
BROOKS, ROSLYN
RICCIO, JULIE BUSBEE
BRAY, CHATHAM
Martinez, Miguel Angel Jr.
MITCHELL, FREDERICK

Foreign Entities:

Foreign Entity Name:
Zhongxing Telecommunications Equipment (ZTE) Corporation
Country :
CHINA
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE ACCOUNTING

Mobile Workforce State Income Tax Simplification Act of 2017, H.R.1393 and S. 540.; Various issues related to the taxation of pass-through entities.

Support for globally consistent accounting standards; Support for independent accounting standard setting process; Support for continued investor protections under Sarbanes-Oxley; S. 610, PCAOB Enforcement Transparency Act of 2017;Small Business Audit Correction Act of 2018, H.R. 6021; John S. McCain National Defense Authorization Act for Fiscal Year 2019, Public Law 115-232 (provisions related to contractor disclosures), S.A. 2583 (disclosures related to certain PCAOB requirements)

Lobbyists:

O'BRIEN, MICHAEL E
BROOKS, ROSLYN
RICCIO, JULIE BUSBEE
BRAY, CHATHAM
Martinez, Miguel Angel Jr.
MITCHELL, FREDERICK

Lobbying on the following issues:

ACCOUNTING TAXATION/INTERNAL REVENUE CODE

Support for continued investor protections under Sarbanes-Oxley; Issues impacting the accounting and auditing profession; Independence of accounting standard setting, Responsible Accounting Standards Act of 2019, H.R. 4565; PCAOB disciplinary proceedings, PCAOB Enforcement Transparency Act of 2019, S. 1256 draft, House bill; PCAOB Whistleblower Protection Act of 2019, H.R. 3625; National Defense Authorization Act for Fiscal Year 2020 (provisions related to contractor disclosures); Issues stemming from the PCAOB's ability to access and inspect audit work of PCAOB-registered audit firms in China

Various issues related to the taxation of pass-through entities

Lobbyists:

O'BRIEN, MICHAEL E
BROOKS, ROSLYN
RICCIO, JULIE BUSBEE
BRAY, CHATHAM
Martinez, Miguel Angel Jr.

Foreign Entities:

Foreign Entity Name:
Block.One
Country :
CAYMAN ISLANDS
Contribution :
$0

Lobbying on the following issues:

ACCOUNTING TAXATION/INTERNAL REVENUE CODE

Support for continued investor protections under Sarbanes-Oxley; Issues impacting the accounting and auditing profession; Independence of accounting standard setting; PCAOB disciplinary proceedings, PCAOB Enforcement Transparency Act of 2019, S. 1256 draft, House bill; Implementation of John S. McCain National Defense Authorization Act for Fiscal Year 2019, Public Law 115-222 (provisions related to contractor disclosures); National Defense Authorization Act for Fiscal Year 2020 (provisions related to contractor disclosures); PCAOB Whistleblower Protection Act of 2019, H.R. 3625

Various issues related to the taxation of pass-through entities; Mobile Workforce State Income Tax Simplification Act, S. 604

Lobbyists:

O'BRIEN, MICHAEL E
BROOKS, ROSLYN
RICCIO, JULIE BUSBEE
BRAY, CHATHAM
Martinez, Miguel Angel Jr.
MITCHELL, FREDERICK

Foreign Entities:

Foreign Entity Name:
Sediver S.p.A
Country :
ITALY
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE ACCOUNTING

Various issues related to the taxation of pass-through entities; Mobile Workforce State Income Tax Simplification Act, S. 604

Support for continued investor protections under Sarbanes-Oxley; Issues impacting the accounting and auditing profession; Independence of accounting standard setting; PCAOB disciplinary proceedings, PCAOB Enforcement Transparency Act of 2019, S. 1256 draft, House bill; Implementation of John S. McCain National Defense Authorization Act for Fiscal Year 2019, Public Law 115-222 (provisions related to contractor disclosures); National Defense Authorization Act for Fiscal Year 2020 (provisions related to contractor disclosures); PCAOB Whistleblower Protection Act of 2019, H.R. 3625

Lobbyists:

O'BRIEN, MICHAEL E
BROOKS, ROSLYN
RICCIO, JULIE BUSBEE
BRAY, CHATHAM
Martinez, Miguel Angel Jr.

Foreign Entities:

Foreign Entity Name :
Roivant Sciences Ltd.
Country :
BERMUDA
Contribution :
$0
-
Foreign Entity Name :
Roivant Sciences GmbH
Country :
SWITZERLAND
Contribution :
$0
-
Foreign Entity Name :
Roivant Sciences Holdings Ltd.
Country :
UNITED KINGDOM
Contribution :
$0
-

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE ACCOUNTING

Various issues related to the taxation of pass-through entities; Mobile Workforce State Income Tax Simplification Act, S. 604

Support for continued investor protections under Sarbanes-Oxley; Issues impacting the accounting and auditing profession; Independence of accounting standard setting; Implementation of John S. McCain National Defense Authorization Act for Fiscal Year 2019, Public Law 115-222 (provisions related to contractor disclosures)

Lobbyists:

O'BRIEN, MICHAEL E
BROOKS, ROSLYN
RICCIO, JULIE BUSBEE
BRAY, CHATHAM
Martinez, Miguel Angel Jr.
MITCHELL, FREDERICK

Foreign Entities:

Foreign Entity Name:
International Fragrance Association
Country :

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

General tax issues affecting corporations, including international tax issues, tax reform, and the Administration's budget proposals.

Lobbyists:

LYON, ANDREW B
Held the following Government positions
Dep. Asst. Secretary for Tax Analysis, Treasury Department

KUMAR, ROHIT
Held the following Government positions
Dep. C. of Staff, Senate Rep. Leader M McConnell

OLSON, PAMELA
Held the following Government positions
Treasury Department Asst. Secretary for Tax Policy

Lieber, Jonathan
Held the following Government positions
Policy Advisor, Senate Majority Leader M. McConnell
Budget Analyst & Chief Economist, Senate Republican Policy Committee
Associate Director, White House National Economic Council
Economist, House Ways and Means Committee.

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

General tax issues affecting corporations, including international tax issues, tax reform, and the Administration's budget proposals.

Lobbyists:

LYON, ANDREW B
Held the following Government positions
Dep. Asst. Secretary for Tax Analysis, Treasury Department

KUMAR, ROHIT
Held the following Government positions
Dep. C. of Staff, Senate Rep. Leader M McConnell

Lieber, Jonathan
Held the following Government positions
Policy Advisor, Senate Majority Leader M. McConnell
Budget Analyst & Chief Economist, Senate Republican Policy Committee
Associate Director, White House National Economic Council
Economist, House Ways and Means Committee.

Foreign Entities:

Foreign Entity Name :
Siemens Healthineers Beteiligungen GmbH & Co. KG
Country :
GERMANY
Contribution :
$0
-
Foreign Entity Name :
Siemens AG
Country :
GERMANY
Contribution :
$0
-
Foreign Entity Name :
Siemens Healthineers AG
Country :
GERMANY
Contribution :
$0
-

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

General tax issues affecting corporations, including international tax issues, tax reform, and the Administration's budget proposals.

Lobbyists:

LYON, ANDREW B
Held the following Government positions
Dep. Asst. Secretary for Tax Analysis, Treasury Department

KUMAR, ROHIT
Held the following Government positions
Dep. C. of Staff, Senate Rep. Leader M McConnell

Lieber, Jonathan
Held the following Government positions
Policy Advisor, Senate Majority Leader M. McConnell
Budget Analyst & Chief Economist, Senate Republican Policy Committee
Associate Director, White House National Economic Council
Economist, House Ways and Means Committee.

Foreign Entities:

Foreign Entity Name:
REC Silicon ASA
Country :
NORWAY
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

General tax issues affecting corporations, including international tax issues, tax reform, and the Administration's budget proposals.

Lobbyists:

LYON, ANDREW B
Held the following Government positions
Dep. Asst. Secretary for Tax Analysis, Treasury Department

KUMAR, ROHIT
Held the following Government positions
Dep. C. of Staff, Senate Rep. Leader M McConnell

Lieber, Jonathan
Held the following Government positions
Policy Advisor, Senate Majority Leader M. McConnell
Budget Analyst & Chief Economist, Senate Republican Policy Committee
Associate Director, White House National Economic Council
Economist, House Ways and Means Committee.

Foreign Entities:

Foreign Entity Name:
William Hill PLC
Country :
UNITED KINGDOM
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

General tax issues affecting corporations, including international tax issues, tax reform, and the Administration's budget proposals.

Lobbyists:

LYON, ANDREW B
Held the following Government positions
Dep. Asst. Secretary for Tax Analysis, Treasury Department

KUMAR, ROHIT
Held the following Government positions
Dep. C. of Staff, Senate Rep. Leader M McConnell

Lieber, Jonathan
Held the following Government positions
Policy Advisor, Senate Majority Leader M. McConnell
Budget Analyst & Chief Economist, Senate Republican Policy Committee
Associate Director, White House National Economic Council
Economist, House Ways and Means Committee.

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

General tax issues affecting corporations, including international tax issues, tax reform, and the Administration's budget proposals.

Lobbyists:

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Issues related to energy tax credits and utility companies.

Lobbyists:

MERRILL, PETER R
SMITH, LINDEN C

Foreign Entities:

Foreign Entity Name :
Roivant Sciences Holdings Ltd.
Country :
UNITED KINGDOM
Contribution :
$0
-
Foreign Entity Name :
Roivant Sciences Ltd.
Country :
BERMUDA
Contribution :
$0
-

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax regulations related to IRC Section 382

Lobbyists:

KUMAR, ROHIT
Held the following Government positions
Dep. Chief of Staff, Senate Republican Leader M. McConnell
Policy Director, Senate Republican Leader W. Frist
General Counsel, Senate Republican Leader T. Lott
Leg. Director, Senator P. Gramm
Dep. Chief Republican Counsel, Senate Banking Cmte

METCALF, TODD
Held the following Government positions
â€‹Democratic Chief Tax Counsel, Senate Finance Committee
Tax Counsel, Senator Ron Wyden
Director of Floor Operations / Counsel, Office of Majority Whip
Leg. Director & Tax Counsel, Rep. W. Jefferson
Leg. Director & Counsel, Rep. M. Sandlin

MAYS, JANICE
Held the following Government positions
â€‹Democratic Chief Counsel and Staff Director, House Ways and Means Committee

PRATER, MARK
Held the following Government positions
â€‹Deputy Staff Director, Chief Tax Counsel, Senate Finance Committee

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax issues affecting U.S. subsidiaries of foreign corporations

Lobbyists:

OLSON, PAMELA
Held the following Government positions
Assistant Secretary for Tax Policy, US Treasury Department

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax issues related to tax-exempt bond authority

Lobbyists:

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax issues affecting U.S. subsidiaries of foreign corporations

Lobbyists:

OLSON, PAMELA
Held the following Government positions
Assistant Secretary for Tax Policy, US Treasury Department

MOENS, BERNARD

Foreign Entities:

Foreign Entity Name :
Resource Capital Fund VI L.P., a Cayman Islands exempt limited partnership
Country :
USA
Contribution :
$0
-
Foreign Entity Name :
Resource Capital Fund V L.P., a Cayman Islands exempt limited partnership
Country :
USA
Contribution :
$0
-

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax issues related to tax-exempt bond authority

Lobbyists:

MCCANDLESS, SCOTT
Held the following Government positions
Tax Counsel, Rep. Tim Griffin
Tax Counsel, Sen. Olympia Snowe

KUMAR, ROHIT
Held the following Government positions
Dep. C. of Staff, Senate Republican Leader Mitch McConnell
Policy Director, Senate Republican Leader William Frist
General Counsel, Senate Republican Leader Trent Lott
Leg. Director, Sen. Phil Gramm
Dep. Chief Repub. Counsel, Senate Banking Cmte

METCALF, TODD
Held the following Government positions
Democratic Chief Tax Counsel, Senate Finance Committee
Tax Counsel, Sen. Ron Wyden
Director of Floor Operations / Counsel, Office of House Majority Whip
Leg Director & Tax Counsel, Rep. W. Jefferson, Leg Director & Counsel,Rep. M Sandlin

MAYS, JANICE
Held the following Government positions
Democratic chief counsel and staff director, House Ways and Means Committee

Foreign Entities:

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Issues related to implementation of the Tax Cuts and Jobs Act.

Lobbyists:

BROWN, PAT

Foreign Entities:

Foreign Entity Name:
REC Silicon ASA
Country :
NORWAY
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax issues related to tax-exempt bond authority

Lobbyists:

CARLSON, DONALD G
Held the following Government positions
Chief of Staff, Rep. Bill Archer

METCALF, TODD
Held the following Government positions
Democratic Chief Tax Counsel, Senate Finance Committee
Tax Counsel, Sen. Ron Wyden
Director of Floor Operations / Counsel, Office of House Majority Whip
Leg Director & Tax Counsel, Rep. W. Jefferson, Leg Director & Counsel,Rep. M Sandlin

MAYS, JANICE
Held the following Government positions
Democratic chief counsel and staff director, House Ways and Means Committee

PRATER, MARK
Held the following Government positions
Deputy Staff Director, Chief Tax Counsel, Senate Finance Committee

Foreign Entities:

Foreign Entity Name:
REC Silicon ASA
Country :
NORWAY
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Issues related to implementation of the Tax Cuts and Jobs Act.

Lobbyists:

BROWN, PAT

Foreign Entities:

Foreign Entity Name:
FUJIFILM Holdings Corporation
Country :

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Issues related to implementation of the Tax Cuts and Jobs Act and Covid-19 Legislation

Lobbyists:

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax issues affecting U.S. subsidiaries of foreign corporations and Covid-19 Legislation

Lobbyists:

PRATER, MARK
Held the following Government positions
Deputy Staff Director, Chief Tax Counsel, Senate Finance Committee

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax legislation and issues related to corporate tax reform

Lobbyists:

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax issues related to Section 199A (P.L. 115-97)

Lobbyists:

SHAPIRO, DAVID

OLSON, PAMELA
Held the following Government positions
Assistant Secretary for Tax Policy, Treasury Department

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax legislation and issues related to corporate tax reform & and tax reform implementation

Lobbyists:

Foreign Entities:

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Partnership tax audit provisions under P.L. 114-74; tax reform issues related to MLPs

Lobbyists:

HAUSWIRTH, MICHAEL
Held the following Government positions
Accountant, Joint Committee on Taxation

MAY, JEFFREY

PRATER, MARK
Held the following Government positions
Deputy Staff Director, Chief Tax Counsel, Senate Finance Committee

Foreign Entities:

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax issues related to the U.S. forest products industry, including energy tax incentives and corporate tax reform

Lobbyists:

MCCANDLESS, SCOTT
Held the following Government positions
Tax Counsel, Rep. Tim Griffin
Tax Counsel, Senator Olympia Snowe

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Partnership tax audit provisions under P.L. 114-74; tax reform issues related to MLPs

Lobbyists:

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax issues related to the U.S. forest products industry, including energy tax incentives and corporate tax reform

Lobbyists:

MCCANDLESS, SCOTT
Held the following Government positions
Tax Counsel, Rep. Tim Griffin
Tax Counsel, Senator Olympia Snowe

Foreign Entities:

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Issues related to implementation of the Tax Cuts and Jobs Act.

Lobbyists:

BROWN, PAT

Foreign Entities:

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax issues related to the U.S. forest products industry, including energy tax incentives and corporate tax reform

Lobbyists:

MCCANDLESS, SCOTT
Held the following Government positions
Tax Counsel, Rep. Tim Griffin
Tax Counsel, Senator Olympia Snowe

GARDNER, ROBERT

Foreign Entities:

Foreign Entity Name:
REC Silicon ASA
Country :
NORWAY
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax issues related to the U.S. forest products industry, including energy tax incentives and corporate tax reform

Lobbyists:

MCCANDLESS, SCOTT
Held the following Government positions
Tax Counsel, Rep. Tim Griffin
Tax Counsel, Senator Olympia Snowe

GARDNER, ROBERT

Foreign Entities:

Foreign Entity Name:
William Hill PLC
Country :
UNITED KINGDOM
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax issues related to the U.S. forest products industry, including energy tax incentives and corporate tax reform

Lobbyists:

MCCANDLESS, SCOTT
Held the following Government positions
Tax Counsel, Rep. Tim Griffin
Tax Counsel, Senator Olympia Snowe

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Issues related to the administration of US tax laws.

Lobbyists:

MCCANDLESS, SCOTT
Held the following Government positions
Tax Counsel, Rep. Tim Griffin
Tax Counsel, Senator Olympia Snowe

OLSON, PAMELA
Held the following Government positions
Assistant Secretary for Tax Policy, US Department of the Treasury

METCALF, TODD
Held the following Government positions
Democratic Chief Tax Counsel, Senate Finance Committee
Tax Counsel, Sen. Ron Wyden
Director of Floor Operations / Counsel, Office of House Majority Whip
Leg. Director & Tax Counsel, Rep. W. Jefferson
Leg. Director & Counsel, Rep. M Sandlin

BROWN, KEVIN
Held the following Government positions
Commissioner-Acting, US Internal Revenue Service

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Partnership tax audit provisions under P.L. 114-74; tax reform issues related to MLPs; issues related to income tax allowances for FERC regulated pipelines; Financing Our Energy Future Act, H.R. 3429, S.1841

Lobbyists:

CARLSON, DONALD G
Held the following Government positions
Chief of Staff, Rep. Bill Archer

HAUSWIRTH, MICHAEL
Held the following Government positions
Accountant, Joint Committee on Taxation

MAY, JEFFREY

PRATER, MARK
Held the following Government positions
Deputy Staff Director, Chief Tax Counsel, Senate Finance Committee

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax issues related to the U.S. forest products industry, including energy tax incentives and corporate tax reform

Lobbyists:

MCCANDLESS, SCOTT
Held the following Government positions
Tax Counsel, Rep. Tim Griffin
Tax Counsel, Senator Olympia Snowe

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Lobbyists:

CARLSON, DONALD G
Held the following Government positions
Chief of Staff, Rep. Bill Archer

HAUSWIRTH, MICHAEL
Held the following Government positions
Accountant, Joint Committee on Taxation

PRATER, MARK
Held the following Government positions
Deputy Staff Director, Chief Tax Counsel, Senate Finance Committee

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax legislation affecting residential and commercial real estate.

Lobbyists:

MCCANDLESS, SCOTT
Held the following Government positions
Tax Counsel, Rep. Tim Griffin
Tax Counsel, Senator Olympia Snowe

FEUERSTEIN, ADAM

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Issues related to the tax treatment of options

Lobbyists:

SHAPIRO, DAVID

Foreign Entities:

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Lobbyists:

Foreign Entities:

Foreign Entity Name:
Barrick Gold Corporation
Country :
CANADA
Contribution :
$0

Lobbying on the following issues:

COMMUNICATIONS/BROADCASTING/RADIO/TV

Issues related to video marketplace competition.

Lobbyists:

MERCADO, MOSES

Lobbying on the following issues:

INDIAN/NATIVE AMERICAN AFFAIRS

Tax issues and land issues

Lobbyists:

LEBEAU, RONDELL REID II

Lobbying on the following issues:

INDIAN/NATIVE AMERICAN AFFAIRS

Corporate Charter Land settlement

Lobbyists:

LEBEAU, RONDELL REID II

Lobbying on the following issues:

MEDICARE/MEDICAID HEALTH ISSUES

Vascular access reimbursement (2019 ASC Proposed Rule); End-Stage Renal Disease Seamless Care Organization (ESCO) Model methodology

Issues related to opioids policies and offsets; H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communities Act); S. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018); S. 2680, Opioid Crisis Response Act of 2018

Lobbyists:

SPICER, TRACY
BARNETT, ELIZABETH MACDONALD

Lobbying on the following issues:

BANKING

Implementation and reform of the Dodd-Frank Wall Street Reform and Consumer Protection Act (P.L.111-203), Consumer Financial Protection Bureau (CFPB) reform, systemic risk, ending "too big to fail", GSE reform, capital requirements, regulatory relief for community banks including S. 2155 implementation, mortgage lending reform and tax relief for community banks. Financial Services Authorization and Financial Services and General Government Appropriations bills, Sub-Chapter S tax relief. Senate confirmation of financial regulators.

Lobbyists:

RUPLI, TIM

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Issues related to implementation of P.L. 115-97

Lobbyists:

BROWN, PAT

Foreign Entities:

Foreign Entity Name:
Interel Holdings, SA/NV
Country :
BELGIUM
Contribution :
$0

Lobbying on the following issues:

DEFENSE VETERANS

Veterans' Programs; Employee Transition; TAP Reform; Widows' tax

Lobbyists:

SCOTT-PAUL, SHANNON L
O'BRIEN, DAVID D
FRIESEN, MATTHEW

Foreign Entities:

Lobbying on the following issues:

BUDGET/APPROPRIATIONS PHARMACY HEALTH ISSUES

H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.

Lobbyists:

ROCK, JAMES W

Foreign Entities:

Lobbying on the following issues:

INDIAN/NATIVE AMERICAN AFFAIRS

Federal Indian Policy; self government; land development; economic development; fee to trust applications.

Lobbyists:

BAKER-SHENK, PHILIP

Foreign Entities:

Lobbying on the following issues:

TRANSPORTATION

Issues related to autonomous vehicles, connected infrastructure, and road safety.

Lobbyists:

DASCHLE, THOMAS
Held the following Government positions
Former U.S. Senator

POLLACK, VERNONICA

Foreign Entities:

Lobbying on the following issues:

DEFENSE

Monitoring issues related to ground robotics programs. Navy carrier launch and recovery systems and vehicle and airframe armor systems. FY20 defense appropriations bill, advanced ground robotics programs

Lobbyists:

COSTELLO, DAVID
SADOWSKI, DANIEL

Foreign Entities:

Lobbying on the following issues:

DEFENSE

FY20 Defense appropriations bill, 2020 NDAA; Navy funding for base projects, support for robust funding for directed energy T&E and test range investment.

Lobbyists:

BACQUE, EMILY
JACQUEZ, LYNNETTE R
LUND, ANDREW CHRISTOPHER

Foreign Entities:

Lobbying on the following issues:

IMMIGRATION AGRICULTURE LABOR ISSUES/ANTITRUST/WORKPLACE

Legislative proposals to provide a reformed agricultural guest worker program and provide earned adjustment of status for foreign agricultural workers.

Legislative proposals to provide a reformed agricultural guest worker program and provide earned adjustment of status for foreign agricultural workers, legislation on the definition of seasonal workers.

Lobbyists:

JACQUEZ, LYNNETTE R
Schulte, Christopher James

Foreign Entities:

Lobbying on the following issues:

HOMELAND SECURITY

monitoring issues related to advanced technologies for Border Security.

Lobbyists:

COSTELLO, DAVID
SADOWSKI, DANIEL

Foreign Entities:

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE AGRICULTURE

BTU Act (S. 628/H.R. 1479)

Community Wood Energy and Innvovative Wood Products program

Lobbyists:

RITA, PATRICK

Foreign Entities:

Foreign Entity Name:
REC Silicon ASA
Country :
NORWAY
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax issues involving carbon capture and sequestration.

Lobbyists:

HILL, GRAHAM
Held the following Government positions
Staff Dir. & Sr. Counsel, House Trans. & Infrastructure

HEIL, CLAYTON
Held the following Government positions
Dep. Staff Dir. & Gen. Counsel, Senate Appropriations

Mueller, John Andrew

LYNCH, THOMAS
Held the following Government positions
Subcommittee Staff Director, Senate EPW

Foreign Entities:

Foreign Entity Name:
REC Silicon ASA
Country :
NORWAY
Contribution :
$0

Lobbying on the following issues:

ANIMALS

HR 1380, Big Cat Public Safety Act. Opposition to bill as drafted.

Lobbyists:

VITELLO, FRANK A
Held the following Government positions
Legislative Staff, House Natural Resources Committee

Foreign Entities:

Foreign Entity Name:
REC Silicon ASA
Country :
NORWAY
Contribution :
$0

Lobbying on the following issues:

INDIAN/NATIVE AMERICAN AFFAIRS

H.R. 312, "Mashpee Wampanoag Tribe Reservation Reaffirmation Act"

Lobbyists:

RUSSELL, JOHN R IV
Lurie, Alexander David
SIBBISON, HEATHER
Nuckolls, Charles Randall
PETOSKEY, ROSE

Foreign Entities:

Foreign Entity Name:
REC Silicon ASA
Country :
NORWAY
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

International tax provisions of P.L. 115-97

Lobbyists:

MERRILL, PETER R

Foreign Entities:

Foreign Entity Name:
REC Silicon ASA
Country :
NORWAY
Contribution :
$0

Lobbying on the following issues:

HEALTH ISSUES

Issues related to Health care, specifically Medicare, Medicaid and the Health Insurance Marketplace.

Lobbyists:

FROGUE, JIM
Clark, Brandon J

Foreign Entities:

Foreign Entity Name:
Karsan Automotive
Country :
TURKEY
Contribution :
$0

Lobbying on the following issues:

TRANSPORTATION NATURAL RESOURCES

Track implementation of Water Infrastructure Improvements for the Nation Act (WIIN Act) P.L. 114-322 Track implementation of the Americas Water Infrastructure Act, P.L. 115-270 Work with water users and Army Corps of Engineers on Bateman Island.

Work on H.R. 278, to direct the Secretary of the Interior to convey certain facilities, easements, and rights-of-way to the Kennewick Irrigation District, and for other purposes. Review and track H.R. 1048, the Yakima River Basin Water Enhancement Project Phase III Act Assist in communications with the Bureau of Reclamation regarding Reclamation policy and contract provisions. Assist with communication with congressional offices and the Bureau of Reclamation regarding water supply issues, reclamation law, and federal budgetary issues. Review and Track Bureau of Reclamation Substantial Change Directive and Standard CMP 10-05. Track and engage on implementation of S.47 John D. Dingell, Jr. Conservation, Management, and Recreation Act, Public Law No: 116-9, as it related to Title Transfer authority

Lobbyists:

Polly, Kris David
LYLE, IAN
YOUNG, TYLER
LINSK, ABBEY

Foreign Entities:

Foreign Entity Name:
Karsan Automotive
Country :
TURKEY
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Issues related to the tax treatment of options

Lobbyists:

SHAPIRO, DAVID

Foreign Entities:

Foreign Entity Name:
Karsan Automotive
Country :
TURKEY
Contribution :
$0

Lobbying on the following issues:

RETIREMENT

Issues relating to Multiemployer Pension Plans

Lobbyists:

LYNCH, TIMOTHY P

Foreign Entities:

Foreign Entity Name:
Karsan Automotive
Country :
TURKEY
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Partnership tax audit provisions under P.L. 114-74; tax reform issues related to MLPs

Lobbyists:

Foreign Entities:

Foreign Entity Name:
Karsan Automotive
Country :
TURKEY
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Issues related to energy tax credits and utility companies.

Lobbyists:

MERRILL, PETER R
SMITH, LINDEN C

Foreign Entities:

Foreign Entity Name:
Strauss Group Ltd.
Country :
ISRAEL
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

International tax provisions of P.L. 115-97

Lobbyists:

MERRILL, PETER R

Foreign Entities:

Foreign Entity Name :
Glencore AG
Country :
SWITZERLAND
Contribution :
$0
-
Foreign Entity Name :
PolyMet Mining Corp.
Country :
CANADA
Contribution :
$0
-

Lobbying on the following issues:

EDUCATION BUDGET/APPROPRIATIONS

Education research issues broadly

Education research issues, as follows: H.R.3055/S.2584, Departments of Commerce and Justice, Science, and Related Agencies Appropriations Act, FY2020 H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020

Lobbyists:

NOCK, ALEXANDER G
KLATT, VICTOR F III
ROBLERO, BLANCHI
ROIBLERO, BLANCHI

Foreign Entities:

Foreign Entity Name:
William Hill PLC
Country :
UNITED KINGDOM
Contribution :
$0

Lobbying on the following issues:

BUDGET/APPROPRIATIONS EDUCATION

H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020, Charter Schools program, including facilities Public Law 115-245, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019 and Continuing Appropriations Act, FY2019, Charter School program reallocation

Charter school issues, generally

Lobbyists:

NOCK, ALEXANDER G
KLATT, VICTOR F III
FRYER, LINDSAY
ROBLERO, BLANCHI

Foreign Entities:

Foreign Entity Name:
FUJIFILM Holdings Corporation
Country :

Lobbying on the following issues:

HEALTH ISSUES ALCOHOL AND DRUG ABUSE

Monitor issues releted to substance abuse and prevention.

Monitor issues related to substance abuse and addiction.

Lobbyists:

ROSEN, BURT E

NORDWIND, WILLIAM R
Held the following Government positions
Counsel, House Energy & Commerce Subcommittee on Telecommunications
Deputy Chief of Staff, Rep. Fred Upton. Counsel, House Energy & Commerce Subcommittee on Telecommunications
Deputy Chief of Staff, Rep. Fred Upton

Foreign Entities:

Foreign Entity Name:
FUJIFILM Holdings Corporation
Country :

Lobbying on the following issues:

MEDICARE/MEDICAID ANIMALS TRADE (DOMESTIC/FOREIGN) COPYRIGHT/PATENT/TRADEMARK LAW ENFORCEMENT/CRIME/CRIMINAL JUSTICE HEALTH ISSUES

Biosimilars Pass-Through Status in Part B Manufacturer Liability in the Medicare Part D Donut Hole H.R. 275 - Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 107 - To amend Title XIX of the Social Security Act to Sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs CMS proposed removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals CMS Advanced Notice of Proposed Rulemaking on International Pricing Index (IPI) Model H.R. 2113- Prescription Drug Sunshine, Transparency, Accountability, and reporting (STAR) Act Biosimilars Part B reimbursement issues H.R. 448 and S.99 - Medicare Drug Price Negotiation Act of 2019 Issues related to the Medicaid Drug Rebate Program Issues related to reform of the Medicare Part D Program

Pesticide Registration Improvement Act (PRIA) Farm Bill Implementation

Trade Agreement USMCA and related policy issues Intellectual Property and Market Access Policy Issues

Drug and Biologic Patent Policy Biopharmaceutical Innovation and Patent Policy Issues S.659 Biologic Patent Transparency Act Bayh-Dole March-in Rights Issues S. 1416, Affordable Prescriptions for Patients Act

Legislative proposals to amend FARA H.R. 1 - For the People Act of 2019

Diabetes and Heart Health Awareness COPD Awareness H.R. 447-Affordable and Safe Prescription Drug Importation Act S.97 - Affordable and Safe Prescription Drug Importation Act S.1169 - Bill to amend the Federal Food, drug and Cosmetic Act Related to Citizens Petitions S.61 and H.R. 478 - Safe and Affordable Drugs from Canada Act of 2019 Issues related to Prescription Drug Counterfeiting and Importation Issues related to Transparency Compulsory Licensing Policy Issues Binding Arbitration Policy Issues Biosimilar development, approval, and reimbursement policy issues H.R. 1520, Purple Book Continuity Act of 2019 Biosimilar Education Issues H.R. 965 - CREATES Act of 2019 The Patient Affordability, Value, and Efficient Act (Draft Legislation) and issues related to value based purchasing arrangements S. 1895, the Lower Health Care Costs Act of 2019 H.R. 2113, Prescription Drug STAR Act H.R. 2296, the Fair Drug Pricing Act of 2019 H.R. 3, Lower Drug Costs Now Act of 2019

Lobbyists:

Walsh, Mary Bridget
Svoboda, Leah D
DAVIS, BILL
MALASI, JULIAN

Foreign Entities:

Foreign Entity Name:
Strauss Group Ltd.
Country :
ISRAEL
Contribution :
$0

Lobbying on the following issues:

DEFENSE

Defense policy and acquisition matters

Lobbyists:

GENTRY, JAMES
O'BRIEN, DAVID D

SANOK KOSTRO, STEPHANIE
Held the following Government positions
PSM House Armed Svc. Cmte.

FRIESEN, MATTHEW

Foreign Entities:

Foreign Entity Name:
Strauss Group Ltd.
Country :
ISRAEL
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

International tax provisions of P.L. 115-97

Lobbyists:

MERRILL, PETER R

Foreign Entities:

Foreign Entity Name:
Strauss Group Ltd.
Country :
ISRAEL
Contribution :
$0

Lobbying on the following issues:

LAW ENFORCEMENT/CRIME/CRIMINAL JUSTICE EDUCATION BUDGET/APPROPRIATIONS TRANSPORTATION

juvenile justice and law-enforcement issues

community college and education issues

funding for community colleges

general transportation issues

Lobbyists:

ANDERSON, REBECCA
BEER, MICHAEL
CARP, BERT
DIJAMES, JENNY
JARDOT, LEO C

RUDD, DAVID
Held the following Government positions
Chief of Staff, Sen. Fritz Hollings Chief of Staff, Sen. Fritz Hollings Chief of Staff, Sen. Fritz Hollings Chief of Staff, Sen. Fritz Hollings

TAYLOR, TRACY D
Held the following Government positions
Sch. C at Agency for International Development Sch. C at Agency for International Development Sch. C at Agency for International Development Sch. C at Agency for International Development

Foreign Entities:

Foreign Entity Name:
Strauss Group Ltd.
Country :
ISRAEL
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Technical issues related to international taxation.

Lobbyists:

MERRILL, PETER R

KUMAR, ROHIT
Held the following Government positions
Dep. Chief of Staff, Senate Republican Leader M. McConnell
Policy Director, Senate Republican Leader W. Frist
General Counsel, Senate Republican Leader T. Lott
Leg. Director, Senator P. Gramm
Dep. Chief Republican Counsel, Senate Banking Cmte

BROWN, PAT

Foreign Entities:

Foreign Entity Name:
Strauss Group Ltd.
Country :
ISRAEL
Contribution :
$0

Lobbying on the following issues:

ECONOMICS/ECONOMIC DEVELOPMENT

Lobbied in support of investment in recycling infrastructure and introducton of legislation establishing grant program related to recycling infrastructure. (Steve Only)Lobbied in support of S. 1982, the Save Our Seas 2.0 Act and the inclusion of recycling infratsructure investment language. (Matt Only)

Lobbyists:

KEELEN, MATTHEW B

BORG, STEPHEN
Held the following Government positions
Deputy Chief of Staff - Representative Timothy V. Johnson

Foreign Entities:

Foreign Entity Name:
Strauss Group Ltd.
Country :
ISRAEL
Contribution :
$0

Lobbying on the following issues:

DEFENSE

National Defense Authorization Act; Military base utilities privatization

Lobbyists:

BOZMAN, JEFFREY
MEARS, ZACHARY

Foreign Entities:

Foreign Entity Name:
Strauss Group Ltd.
Country :
ISRAEL
Contribution :
$0

Lobbying on the following issues:

BUDGET/APPROPRIATIONS HEALTH ISSUES

Pursuit of federal funding in the Labor-HHS legislation for Children's Hospital GME payments.

Medicaid issues affecting children's access to health care; H.R. 1839, Support for ACE Kids Act legislation.

Lobbyists:

TOFIL, LISA
BRADNER, ROBERT Hunt

Foreign Entities:

Foreign Entity Name:
Strauss Group Ltd.
Country :
ISRAEL
Contribution :
$0

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Tax regulations related to IRC Section 382.

Lobbyists:

KUMAR, ROHIT
Held the following Government positions
â€‹Dep. Chief of Staff, Senate Republican Leader M. McConnell
Policy Director, Senate Republican Leader W. Frist
General Counsel, Senate Republican Leader T. Lott
Leg. Director, Senator P. Gramm
Dep. Chief Republican Counsel, Senate Banking Cmte

METCALF, TODD
Held the following Government positions
Democratic Chief Tax Counsel, Senate Finance Committee
Tax Counsel, Senator Ron Wyden
Director of Floor Operations / Counsel, Office of Majority Whip
Leg. Director & Tax Counsel, Rep. W. Jefferson
Leg. Director & Counsel, Rep. M. Sandlin

MAYS, JANICE
Held the following Government positions
Democratic Chief Counsel and Staff Director, House Ways and Means Committee

PRATER, MARK
Held the following Government positions
Deputy Staff Director, Chief Tax Counsel, Senate Finance Committee

Foreign Entities:

Foreign Entity Name:
Telefonaktiebolaget LM Ericsson
Country :
SWEDEN
Contribution :
$0

Lobbying on the following issues:

EDUCATION

Advancing education and literacy issues

Lobbyists:

LYONS, JESSIE

Foreign Entities:

Foreign Entity Name :
Red Electrica Corporacion SA
Country :
SPAIN
Contribution :
$0
-
Foreign Entity Name :
Red Electrica Sistemas de Telecomunicaciones, SAU
Country :
SPAIN
Contribution :
$0
-
Foreign Entity Name :
Hispamar Satelites S.A.
Country :
BRAZIL
Contribution :
$0
-

Lobbying on the following issues:

HEALTH ISSUES LABOR ISSUES/ANTITRUST/WORKPLACE

Issues related to the individual marketplace Health insurance tax and general tax issues Part D Drug pricing issues

Issues related to competition policy

Lobbyists:

MOSCHELLA, WILLIAM
Held the following Government positions
â€‹PrincAssocDepAG DOJ,AsstAG DOJ,ChfLegCouns/Parliam Hs Judic Comm,ChfInvestigativeCouns Hs Judic Comm,GC Hs Rules Comm,Couns Hs Judic Comm,Couns/Parliam Hs Gov Rel Comm,SrLegAsst Rep Frank Wolf,LegAsst Rep Frank Wolf,ComputerSysManager Rep Frank Wolf

HARJU, LORI
IOVINO, CHARLYN
Sullivan, Russell W.
FELDER, EMILY

Lobbying on the following issues:

TRADE (DOMESTIC/FOREIGN) GOVERNMENT ISSUES

Caribbean Basin Trade Partnership Act (CBTPA) extension (H.R. 991/ S. 2473)

Border enforcement issues

Lobbyists:

SORINI, RONALD
SAMET, ANDREW
COSTELLO, MEGAN
MURTHA, CHELSEA

Lobbying on the following issues:

BUDGET/APPROPRIATIONS HEALTH ISSUES MEDICARE/MEDICAID

Issues related to continuing care hospitals; IRF payment and coverage; Medicare Advantage and Prior Authorization; regulatory relief and reform issues; unified post-acute care payment systems.

Unified post-acute care payment system; Medicare Advantage and Prior Authorization including H.R.3107; Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; value based purchasing issues, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue; Preserving Rehabilitation Innovation Centers Act (H.R.1901/S.594); Improving Seniors Timely Access to Care Act (H.R.3107; The BETTER Act (H.R.3417).

Lobbyists:

KENDRICK, MARTHA
TOMAR, ELI
HUSSEY, KENDALL BYRUM
NOLAN, JULIE
AGNELLO, LOUIS

Lobbying on the following issues:

MEDICARE/MEDICAID

Yet to be introduced CARE Act, Surprise Medical Billing Legislation.

Lobbyists:

LEE, PAUL
Seibert-Bailey, Devon Elizabeth

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

International tax provisions of P.L. 115-97

Lobbyists:

Lobbying on the following issues:

HEALTH ISSUES

legislation and regulations affecting marketing and commercialization of prescription and non-prescription drugs

Lobbyists:

KLUG, SCOTT L
Held the following Government positions
Member of Congress 1991 to 1999

Walsh, Jennifer Fitzgerald
Held the following Government positions
Administrative Assistant, Deputy COS, COS: Rep. Dennis Cardoza
Field Representative: Rep. Vic Fazio
Staff Assistant, Program Director, Executive Assistant: House Democratic Caucus

Lobbying on the following issues:

IMMIGRATION GOVERNMENT ISSUES LABOR ISSUES/ANTITRUST/WORKPLACE BANKING TAXATION/INTERNAL REVENUE CODE CONSUMER ISSUES/SAFETY/PRODUCTS HEALTH ISSUES ROADS/HIGHWAY BUDGET/APPROPRIATIONS FOREIGN RELATIONS SMALL BUSINESS TRADE (DOMESTIC/FOREIGN) ENVIRONMENT/SUPERFUND TRANSPORTATION

Immigration issues-comprehensive immigration reform, H2B visa reform efforts; Employment verification legislation; Temporary Protective Status; Deferred Action for Childhood Arrivals Program; Workforce for an Expanding Economy Act, H.R. 1740;

TRAC Act; Bid Shopping; Bid Listing; Buy American Reform; Protecting the attendance of federal employees at non-federal conferences; Plans for mandating verification systems/policies for employers; S.1434- Construction Consensus Procurement Improvement Act; H.R.2344- Small Business Payment act for Performance Act of 2019

Representation Election Procedures, Efforts to mandate employment verification system for employers; Definition of independent contractor; Multi-employer Pension Reform, Working Families Flexibility Act; Implementation of Workforce Innovation and Opportunity Act; EEOC Transparency and Accountability, Fair and Open Competition Act; H.R. 1858, S. 907, Paid Leave, Joint Employer, Career and Technical Education, Apprenticeship Executive Order; Work Opportunity Tax Credit (WOTC); Worker centers; Apprenticeships in construction; Paycheck Fairness Act, H.R. 7/ S.270, Family Leave, S.839/H.R.3497, the JOBS Act, USA Workforce Tax credit; Secure Act H.R. 1994; H.R. 397- Rehabilitation for Multiemployer Pension Act; S.1306/H.R.2474- the Protecting the Right to Organize Act; S.2557- Student Aid Improvement Act; H.R.4674- the College Affordability Act

H.R.2513/S.1978, the Corporate Transparency Act; S.2563- ILLICIT Cash Act; Beneficial Ownership legislation

Highway Trust Fund Solvency; Financial Accounting Standards Board issues; Repeal of health insurance tax; POC method accounting; Energy Efficiency Tax Incentives Act (179D);Sustainable Water Infrastructure Act; Private Activity Bond CAP Increase for Qualified Highway and Freight Facilities; Lookback Accounting; Estate Tax; Pass-through business taxation; Implementation of 199A; Cash accounting; State and Local Tax Deduction (SALT); Net operating losses (NOLs); Municipal bonds depreciation; Advance Refunding of Municipal Bonds; Limitation on net interest expense, 163(j); Main Street Tax Certainty Act, (H.R. 216/S.1149); Treasury/IRS Regulation on Qualified Business Income Deduction; Opportunity Zones; Death Tax Repeal Act (H.R. 218/ S.215); Move America Act (S. 146/ H.R. 1508); Public Building Renewal Act (H.R. 1251/ S. 932); Build Act (S. 352/H.R.2541); Rapid Act (S. 353/H.R.2475; Infrastructure Package; Foreign Investment in Real Property Tax Act; Work Opportunity Tax Credit (WOTC); H.R.3301- the Taxpayer Certainty and Disaster Tax Relief Act of 2019; New Market Tax Credits (NMTC); H.R.1865- Further Consolidated Appropriations Act of 2020; H.R.1869- Qualified Improvement Property technical correction

Fair and Open Competition Act, H.R. 1858/S. 907; Susan Harwood Training Grants; Opioid Crisis; H.R. 3668- Asuncion Valdivia Heat Illness and Fatality Prevention Act of 2019

Employer Mandate Repeal;Commonsense Reporting, Middle Class Health Benefits Tax Repeal Act; HR 1.R. 748/ S.684, Tax Exclusion; Association Health Plans; Surprise Billing, Health Insurance Tax Relief Act S. 172/ H.R. 1398; Jobs and Premium Protection Act S.80; Drug Pricing, S.1510/H.R.2782- Employee Flexibility Act of 2019; S.1895- the Lower Health Care Costs Act

Monitor implementation Fixing America's Surface Transportation (FAST) Act; Highway Trust Fund solvency; Surface Transportation funding; Legislative proposals to provide additional funding for federal highway & transit programs; FY 2020 THUD appropriations; Private Activity Bonds (PABs); H.R.2541/S. 352 BUILD Act, S. 353/H.R.2475- the RAPID Act; Hours of Service regulations; S.2303- America's Transportation Infrastructure Act; Reauthorization of Federal Surface Transportation programs

FY 2020 appropriations for federal construction programs to provide for economic activity for Army Corps of Engineers - Civil Works; DOD Military Construction/VA; Labor Appropriations - Agency Budget Requests; GSA Federal Building Fund (FBF) FY 2020; FY 2020 Energy & Water Appropriations; Transportation & HUD Appropriations; FY 2020 Interior and Environment Appropriations - SRF Funding; DERA Funding; FY 2020 Labor, Health and Human Services; H.R.2500/S.1790- National Defense Authorization Act for FY2020; H.R.1865- Further Consolidated Appropriations Act of 2020; S.1992- Bill to amend the FAST Act to repeal a rescission of funds; H.R.1158- Consolidated Appropriations Act of 2020; H.R.3055- Further Continuing Appropriations Act, 2020 & Further Health Extenders Act of 2019

Overseas Buildings Operations; Embassy construction

Reverse Auctions; Bid Listing; Bid Shopping; Design-Build Construction; HR 2344, Small Business Payment for Performance Act; H.R.226- Clarity on Small Business Participation in Category Management Act of 2019

USMCA; H.R.5430- USMCA Implementation Act; Section 232 Steel and Aluminum Tariffs

Water Infrastructure funding; Grants and Loans; Provisions relating to transportation planning and environmental review; Rule relating to federal jurisdiction over "Waters of the United States" for the purpose of Clean Water Act permits; Monitor implementation of the Water Resources Development and Reform Act of 2014, 2016, and 2018; Diesel Emission Reduction Act (DERA) funding and re-authorization H.R. 1768, S. 747; H.R. 1497 Water Quality Protection + Job Creation Act; Water Resources Development Act of 2020; H.R.3702- the Reforming Disaster Recovery Act; H.R.4634- Terrorism Risk Insurance Act; National Environmental Policy Act; H.R.535- PFAS Action Act of 2019; Endangered Species Act Modernization

Monitor implementation of the FAST Act; Highway Trust Fund solvency; Surface Transpiration funding, FY 2020 Department of Transportation Appropriations; Disadvantaged Business Enterprise Program; Harbor Maintenance Trust Fund; Inland Waterways Trust Fund; Increase passenger facility charge; Hours of Service; BUILD Act (S.352/H.R.2541); RAPID Act (S.353/H.R.2475); S. 146/ H.R. 1508 Move America Act; Infrastructure Package; Reauthorization of federal surface transportation programs; H.R.5430- USMCA Implementation Act; S.2302- America's Transportation Infrastructure Act of 2019; H.R.2440- Full Utilization of Harbor Maintenance Trust Fund Act; S.1992- a bill to amend the FAST Act to repeal a rescission of funds

Lobbyists:

YOUNG, JAMES
DEERY, BRIAN
SANDHERR, STEPHEN E
CHRISTIANSON, JAMES
HOWARD, JORDAN
Gray, Allen S.
TURKSTRA, MATTHEW

BARRETT, MURPHIE
Held the following Government positions
Former Republican Staff Director, House Subcommittee on Highways and Transit Former Republican Staff Director, House Subcommittee on Highways and Transit Former Republican Staff Director, House Subcommittee on Highways and Transit Former Republican Staff Director, House Subcommittee on Highways and Transit Former Republican Staff Director, House Subcommittee on Highways and Transit

Lobbying on the following issues:

ECONOMICS/ECONOMIC DEVELOPMENT IMMIGRATION

Extension of the EB-5 Regional Centers program

Lobbyists:

BORNSTEIN, THEODORE H
KLUG, SCOTT L
Walsh, Jennifer Fitzgerald

Lobbying on the following issues:

COPYRIGHT/PATENT/TRADEMARK HEALTH ISSUES TRADE (DOMESTIC/FOREIGN)

Issues related to pharmaceutical patents.

Drug pricing issues, including the IPI Drug Pricing Model, Prescription Drug Pricing Act (S. 2543), the Lower Costs, More Cures Act (S. 3129) and other congressional proposals.

Support for biologics data exclusivity period in USMCA.

Lobbyists:

ELLIS, RYAN
Bates, Gordon Hunter HUNTER
O'Brien, Lauren B

HIGGINS, CASEY
Held the following Government positions
Asst to Spkr for Policy and Trade Cnsl, Paul Ryan, Nov 15-Jan 19
Trade Cncl to House Ways & Means, Jan 15-Nov 15
LC to Rep. Paul Ryan, Oct 11-Jan 15
Law Clrk House Budget Comm, Sep 09-May 10.

Lobbying on the following issues:

SMALL BUSINESS AGRICULTURE TRADE (DOMESTIC/FOREIGN)

Advocate for access to small business lending programs, including in H.R. 748, the CARES Act.

Monitor issues related to sugar reform.

Educate Members of Congress on the global supply chain for cocoa; monitor trade policy impacting industry inputs and U.S. tariff policy.

Lobbyists:

VENABLE, NICOLE
PATROLIA, EMILY
ENOCH, QUINCY

Lobbying on the following issues:

COPYRIGHT/PATENT/TRADEMARK TRADE (DOMESTIC/FOREIGN) EDUCATION TELECOMMUNICATIONS TRANSPORTATION

The STRONGER Patents Act (HR 3666; S. 2082) Amendments to US Japan Free Trade Agreement

International Trade Advocacy Export control guidance Amendments to US Japan Free Trade Agreement

Advocacy on spectrum 5G, connected vehicles, smart cities, IoT, privacy and federal funding for student connectivity and devices.

Lobbyists:

TORNQUIST, ALICE
SELF, LAURIE C
FRASER, REBECCA

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Matters relating to section 965 of the tax code. H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act.

Lobbyists:

MIGDAIL, EVAN M
GIERACH, MELISSA

Lobbying on the following issues:

HOMELAND SECURITY SCIENCE/TECHNOLOGY ANIMALS AGRICULTURE MEDICAL/DISEASE RESEARCH/CLINICAL LABS FOOD INDUSTRY (SAFETY, LABELING, ETC.) HEALTH ISSUES TRADE (DOMESTIC/FOREIGN) FUEL/GAS/OIL BUDGET/APPROPRIATIONS MEDICARE/MEDICAID CONSUMER ISSUES/SAFETY/PRODUCTS TAXATION/INTERNAL REVENUE CODE SMALL BUSINESS CHEMICALS/CHEMICAL INDUSTRY ENERGY/NUCLEAR COPYRIGHT/PATENT/TRADEMARK

Engineering Biology ---H.R.4373: Engineering Biology Research and Development Act ---Bioeconomy Research and Development Act Discussion Draft

Genetically Engineered (GE) Animals ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ------Amendment on GE Salmon Labeling ---FDA Regulatory Approach to Animal Biotechnology ---Priority Zoonotic Animal Drugs ---USDA Authority to Review Animal Biotechnology

Coronavirus (COVID-19) Pandemic ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) ---Priority Zoonotic Animal Drugs Foreign Agricultural Biotechnology Laws and Regulations ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations ---Korea Biotechnology Regulations Funding for Biomass Crop Assistance Program ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 Funding for the USDA ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Farm Bill Programs Energy Title IX ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) Genetically Engineered (GE) Animals ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ------Amendment on GE Salmon Labeling ---FDA Regulatory Approach to Animal Biotechnology ---Priority Zoonotic Animal Drugs ---USDA Authority to Review Animal Biotechnology Genetically Engineered (GE) Plants ---EPA Regulatory Approach to Gene Editing The United States-Mexico-Canada Agreement ---Ag-Biotech Provisions US-China Trade Negotiations ---Ag Biotech Provisions US-Japan Trade Agreement ---Ag-Biotech Provisions US-UK Trade Agreement ---Ag-Biotech Provisions USDA/APHIS Agricultural Biotechnology Regulations ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Regulatory Treatment of Gene Edited Products

Biodefense Research, Development and Procurement Issues (Non-funding) ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 ---Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act of 2019 ---National Biodefense Strategy Funding for Antimicrobial Resistance Programs ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.4100/S.1712: DISARM Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for National Institutes of Health ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021

21st Century Cures Act 2.0 ---RFI from House Energy and Commerce Committee 340B Drug Discount Program ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Biodefense Research, Development and Procurement Issues (Non-funding) ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 ---Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act of 2019 ---National Biodefense Strategy Biosimilars ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1520: Purple Book Continuity Act of 2019 ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.659: Biologic Patent Transparency Act of 2019 ---Implementation and Reauthorization of the Biosimilar User Fee Act of 2017 Coronavirus (COVID-19) Pandemic ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.4100/S.1712: DISARM Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 ---Drug Supply Chain Management ---Home Administration of Part B Drugs ---Medicare Reimbursement Policies ---Patient Cost-Sharing and Smoothing ---R&D Funding for Medical Countermeasures ---Reasonable Pricing Provisions Diagnostics and Personalized Medicine Regulation and Oversight ---H.R.6102/S3404: VALID Act of 2020 Drug Evaluation and Review ---S.1617: Second Look at Drug Patents Act of 2019 ---Patient-Focused Drug Development ---Regulatory Reform & Modernization ---Use of Real-World Evidence Drug Importation ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---General Drug Manufacturing, Quality & Distribution ---Drug Shortages ---Supply Chain Integrity and Traceability Drug Patenting ---H.R.19/S.3129: Lower Costs, More Cures Act of 2019 ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.1188/S.366: Forcing Limits on Abusive and Tumultuous prices (FLAT) prices Act of 2019 ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1503: Orange Book Transparency Act of 2019 ---H.R.1520: Purple Book Continuity Act of 2019 ---H.R.3199: Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 ---H.R.3991: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 ---S.1416/H.R.4398/H.R.3991/H.R.5133: Affordable Prescriptions for Patients Act of 2019 ---S.1617: Second Look at Drug Patents Act of 2019 ---S.1895: Lower Health Care Costs for Patients Act of 2019 ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.659: Biologic Patent Transparency Act of 2019 Drug Pricing ---H.R.3: Lower Drug Costs Now Act of 2019 ---H.R.19/S.3129: Lower Costs, More Cures Act of 2019 ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.1188/S.366: Forcing Limits on Abusive and Tumultuous Prices (FLAT) Prices Act of 2019 ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1503: Orange Book Transparency Act of 2019 ---H.R.1520: Purple Book Continuity Act of 2019 ---H.R.2376/S.1227: Prescription Pricing for the People Act of 2019 ---H.R.2387: STOP GAMES Act of 2019 ---H.R.3199 Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 ---H.R.3991 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.1416/H.R.4398/H.R.3991/H.R.5133: Affordable Prescriptions for Patients Act of 2019 ---S.1617: Second Look at Drug Patents Act of 2019 ---S.1895: Lower Health Care Costs for Patients Act of 2019 ---S.2543: Prescription Drug Pricing Reduction Act of 2019 ---CMMI Authority ---General ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---International Pricing Index Proposal ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 ---Reasonable Pricing Provisions Funding for Antimicrobial Resistance Programs ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.4100/S.1712: DISARM Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for FDA ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 Funding for Health Resources and Services Administration (HRSA) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for National Institutes of Health ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Medicaid ---H.R.5741: Strengthening Innovation in Medicare and Medicaid Act of 2020 ---S.2543: Prescription Drug Pricing Reduction Act of 2019 ---Alternative payment arrangements for gene therapies ---Pricing and Rebates Opioid Crisis ---General ---Implementation of the SUPPORT for Patients and Communities Act of 2018 Orphan Drug Issues ---H.R.4712: Fairness in Orphan Drug Exclusivity Act of 2019 ---Tax Credit Rare Pediatric Disease Priority Review ---H.R.4439: Creating Hope Reathorization Act of 2019 Reimbursement and Coverage of Innovative Products ---H.R.3: Lower Drug Costs Now Act of 2019 ---H.R.19/S.3129: Lower Costs, More Cures Act of 2019 ---S.2326: New Opportunities for Value that Extend Lives (NOVEL) Act of 2019 ---S.2543: Prescription Drug Pricing Reduction Act of 2019 ---Administration Rebate Rule ---CMMI Authority ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---Home Administration of Part B Drugs ---International Pricing Index Proposal ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Patient Cost-Sharing and Smoothing ---Step Therapy ---Support of Patient Premiums and Cost-Sharing Obligations ---Surprise Billing ---Value-based Contracting and Communications The United States-Mexico-Canada Agreement ---IP Provisions US-China Trade Negotiations ---IP Provisions US-Japan Trade Agreement ---IP Provisions US-Kenya Trade Agreement ---IP Provisions US-UK Trade Agreement ---IP Provisions Vaccine Injury Compensation Program Tax ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 202 ---H.R.1973/S.1654: Vaccine Access Improvement Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 Vaccines and Infectious Diseases ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.5076/S.1872: Protecting Seniors through Immunizations Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 ---Vaccine and Anti-Microbial Resistance Product Development and Incentives

Committee on Foreign Investment in the United States (CFIUS) ---Implementation of Foreign Investment Risk Review Modernization Act (FIRRMA) of 2017 Drug Importation ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---General Drug Pricing ---International Pricing Index Proposal Foreign Agricultural Biotechnology Laws and Regulations ---EU Ag-Biotech Policies and Regulations ---Korea Biotechnology Regulations Intellectual Property International Enforcement ---China ---India The United States-Mexico-Canada Agreement ---Ag-Biotech Provisions ---IP Provisions US-China Trade Negotiations ---Ag Biotech Provisions ---IP Provisions US-Japan Trade Agreement ---Ag-Biotech Provisions ---IP Provisions US-Kenya Trade Agreement ---IP Provisions US-UK Trade Agreement ---Ag-Biotech Provisions ---IP Provisions World Trade Organization - Special 301 Submissions ---China ---India

Biofuels (Non-Funding) ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.3006: Support RFS Integrity Act of 2019 ---H.R.3249/S.1841: Financing Our Energy Future Act of 2019 ---H.R.4385: Small Refinery Exemption Fairness Act of 2019 ---H.R.6379: Take Responsibility for Workers and Families Act of 2020 ---S.1840: A bill to establish certain requirements for the small refineries exemption of the renewable fuels provisions under the Clean Air Act, and for other purposes. ---Climate Leadership and Environmental Action for our Nations (CLEAN) Future Act (Discussion Draft House) ---Incentives for Sustainable Aviation Fuels ---RFI from House Select Committee on the Climate Crisis ---Small Refinery Waivers ---Sustainable Aviation Fuels Tax Credit Funding for Biofuels ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6379: Take Responsibility for Workers and Families Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2021 ---Energy and Water Development and Related Agencies Appropriations Act for FY 2021 ---Incentives for Sustainable Aviation Fuels ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) ---Transportation, and Housing and Urban Development, and Related Agencies Act for FY 2021 Funding for Biomass Crop Assistance Program ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 Funding for Biorefineries ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Energy and Water Development and Related Agencies Appropriations Act for FY 2021 ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) Renewable Fuel Standard (RFS) ---H.R.3006: Support RFS Integrity Act of 2019 ---H.R.4385: Small Refinery Exemption Fairness Act of 2019 ---S.1840: A bill to establish certain requirements for the small refineries exemption of the renewable fuels provisions under the Clean Air Act, and for other purposes. ---Climate Leadership and Environmental Action for our Nations (CLEAN) Future Act (Discussion Draft House) ---Cellulosic Registration Applications for Corn Kernel Fiber ---RFI from House Select Committee on the Climate Crisis ---RFS Reform ---Small Refinery Waivers

Coronavirus (COVID-19) Pandemic ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 Funding for Antimicrobial Resistance Programs ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.4100/S.1712: DISARM Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for Biofuels ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6379: Take Responsibility for Workers and Families Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2021 ---Energy and Water Development and Related Agencies Appropriations Act for FY 2021 ---Incentives for Sustainable Aviation Fuels ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) ---Transportation, and Housing and Urban Development, and Related Agencies Act for FY 2021 Funding for Biomass Crop Assistance Program ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 Funding for Biorefineries ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Energy and Water Development and Related Agencies Appropriations Act for FY 2021 ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) Funding for Coronavirus (COVID-19) Small Business Loans ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 Funding for FDA ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 Funding for Health Resources and Services Administration (HRSA) - Vaccine Injury Compensation Program (VICP) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for National Institutes of Health ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for Renewable Chemicals/Bio-based Products ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Energy and Water Development and Related Agencies Appropriations Act for FY 2021 ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for the HHS Office of Infectious Disease and HIV/AIDS Policy ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for the USDA ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Farm Bill Programs Energy Title IX ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC)

21st Century Cures Act 2.0 ---RFI from House Energy and Commerce Committee Coronavirus (COVID-19) Pandemic ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 ---Home Administration of Part B Drugs ---Medicare Reimbursement Policies ---Patient Cost-Sharing and Smoothing ---Reasonable Pricing Provisions Drug Pricing ---H.R.3: Lower Drug Costs Now Act of 2019 ---H.R.19/S.3129: Lower Costs, More Cures Act of 2019 ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.1188/S.366: Forcing Limits on Abusive and Tumultuous (FLAT) Prices Act of 2019 ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1503: Orange Book Transparency Act of 2019 ---H.R.1520: Purple Book Continuity Act of 2019 ---H.R.2376/S.1227: Prescription Pricing for the People Act of 2019 ---H.R.2387: STOP GAMES Act of 2019 ---H.R.3199 Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 ---H.R.3991 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.1416/H.R.4398/H.R.3991/H.R.5133: Affordable Prescriptions for Patients Act of 2019 ---S.1617: Second Look at Drug Patents Act of 2019 ---S.1895: Lower Health Care Costs for Patients Act of 2019 ---S.2543: Prescription Drug Pricing Reduction Act of 2019 ---CMMI Authority ---General ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---International Pricing Index Proposal ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 ---Reasonable Pricing Provisions Medicaid ---H.R.5741: Strengthening Innovation in Medicare and Medicaid Act of 2020 ---Alternative payment arrangements for gene therapies ---Pricing and Rebates Reimbursement and Coverage of Innovative Products ---H.R.3: Lower Drug Costs Now Act of 2019 ---H.R.19/S.3129: Lower Costs, More Cures Act of 2019 ---S.2326: New Opportunities for Value that Extend Lives (NOVEL) Act of 2019 ---S.2543: Prescription Drug Pricing Reduction Act of 2019 ---Administration Rebate Rule ---CMMI Authority ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---Home Administration of Part B Drugs ---International Pricing Index Proposal ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Patient Cost-Sharing and Smoothing ---Step Therapy ---Support of Patient Premiums and Cost-Sharing Obligations ---Surprise Billing ---Value-based Contracting and Communications Vaccines and Infectious Diseases ---H.R.5076/S.1872: Protecting Seniors through Immunizations Act of 2019

Drug Importation ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---General Genetically Engineered (GE) Animals ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ------Amendment on GE Salmon Labeling ---FDA Regulatory Approach to Animal Biotechnology ---Priority Zoonotic Animal Drugs ---USDA Authority to Review Animal Biotechnology Opioid Crisis ---General ---Implementation of the SUPPORT for Patients and Communities Act of 2018

Biofuels (Non-Funding) ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.3249/S.1841: Financing Our Energy Future Act of 2019 ---H.R.6379: Take Responsibility for Workers and Families Act of 2020 ---Incentives for Sustainable Aviation Fuels ---Sustainable Aviation Fuels Tax Credit Capital Formation Investment Incentives ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 ---Introduction of the American Innovation Act in the Senate ---Reform of Net Operating Loss Rules ---Reintroduction of the American Innovation Act in the House Orphan Drug Issues ---Tax Credit Qualified Small Business Stock (QSBS) Renewable Chemicals/Bio-based Products (Non-Funding) ---H.R.3249/S.1841: Financing Our Energy Future Act of 2019 ---Investment Tax Credit ---Production Tax Credit Research & Development Tax Credit Reforms ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 ---H.R.6379: Take Responsibility for Workers and Families Act of 2020 ---Expensing of R&D Expenditures ---Incentives for Sustainable Aviation Fuels ---R&D Payroll Credit Vaccine Injury Compensation Tax ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.1973/S.1654: Vaccine Access Improvement Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020

Capital Market Enhancements ---Accredited Investor Definition ---Amended Definition of Smaller Reporting Company Coronavirus (COVID-19) Small Business Loans (Non-Funding) ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Affiliation ---Eligibility Funding for Coronavirus (COVID-19) Small Business Loans ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 Proxy Advisory Services ---H.R.4015: Corporate Governance Reform and Transparency Act of 2017 ---S.3614: Corporate Governance Fairness Act of 2018 ---Impact of Policies on Small Public Companies Sarbanes Oxley Section 404 (b) ---H.R.3886/S.452: Fostering Innovation Act of 2019 ---Small Issuer Exemption Short Selling Transparency Small Business Innovation Research (SBIR) Program

Funding for Renewable Chemicals/Bio-based Products ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Energy and Water Development and Related Agencies Appropriations Act for FY 2021 ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) Renewable Chemicals/Bio-based Products (Non-Funding) ---H.R.2051/S.999: Sustainable Chemistry Research and Development Act of 2019 ---H.R.3249/S.1841: Financing Our Energy Future Act of 2019 ---Bioeconomy Research and Development Act of 2020 (Discussion Draft House) ---Climate Leadership and Environmental Action for our Nations (CLEAN) Future Act (Discussion Draft House) ---Investment Tax Credit ---Production Tax Credit

Bayh-Dole Act/Tech Transfer ---Bayh-Dole 40th Anniversary ---March-In Rights Compulsory Licensing ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 Drug Patenting ---H.R.19/S.3129: Lower Costs, More Cures Act of 2019 ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.1188/S.366: Forcing Limits on Abusive and Tumultuous prices (FLAT) prices Act of 2019 ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1503: Orange Book Transparency Act of 2019 ---H.R.1520: Purple Book Continuity Act of 2019 ---H.R.3199: Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 ---H.R.3991: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.659: Biologic Patent Transparency Act of 2019 ---S.1416/H.R.4398/H.R.3991/H.R.5133: Affordable Prescriptions for Patients Act of 2019 ---S.1617: Second Look at Drug Patents Act of 2019 ---S.1895: Lower Health Care Costs for Patients Act of 2019 Intellectual Property International Enforcement ---China ---India Inter Partes Review ---H.R.1503: Orange Book Transparency Act of 2019 ---H.R.3666/S.2082: Support Technology and Research for Our Nation's Growth and Economic Resilience (STRONGER) Patents Act of 2019 ---S.1617: Second Look at Drug Patents Act of 2019 ---S.440 PACED Act of 2019 ---Implementation of the America Invents Act of 2011 Patent Reform ---H.R.3199: Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 ---Patent Litigation Reforms Patenting of Biological Inventions ---Section 101 Modernization The United States-Mexico-Canada Agreement ---IP Provisions US-China Trade Negotiations ---IP Provisions US-Japan Trade Agreement ---IP Provisions US-Kenya Trade Agreement ---IP Provisions US-UK Trade Agreement ---IP Provisions

Lobbyists:

HAGGERTY, JEANNE
SAUER, HANSJORG
ESHAM, CARTIER
O'MARA, MATTHEW
O'Brien, Dana Maurice Jr
ARTERTON, CAMERON
GREGORIAN, JAMIE
KUNKLER, KYLE
FRITTS, CHARLES H
LACHMANN, DAVID
MURPHY, JOHN
BRAND, MELISSA
Alexander, Hayley B
LUTT, ERICK
CONNOR, ANDREW
Brandewie, Claire Willis
CONNER, ANDREW
HARTLEY, SHEA
MATTOON, MICHAEL
HACKETT, REBECCA AIKEN
BRUNET, THOMAS

Lobbying on the following issues:

BUDGET/APPROPRIATIONS INDIAN/NATIVE AMERICAN AFFAIRS

Tribal programs, Department of Interior Special Diabetes Program for Indians funding Johnson O'Malley Grant Program and EPA Tribal General Assistance Grant Program HR 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Provisions affecting Tribes and tribal governments. HR 6201 - Families First Coronavirus Response Act - Provisions affecting Tribes and tribal governments. S. 3549 - Coronavirus Aid, Relief, and Economic Security Act - Provisions affecting Tribes and tribal governments.

Land into trust issues and reform. Water settlement. Tribe's water rights and water leasing issues. Self-Governance of health care for tribal members. S. 227 - Savanna's Act General Native American issues.

Lobbyists:

LOVING, JOHN CF
HARMALA, ROBERT ESQ

Williams, Byron Craig Jr.
Held the following Government positions
Intern in Rep. Lujan Grisham's Office Intern in Rep. Lujan Grisham's Office

Lobbying on the following issues:

TRADE (DOMESTIC/FOREIGN) NATURAL RESOURCES

General trade issues

General mining issues

Lobbyists:

KAVINOKY, PAUL
Held the following Government positions
Legislative Director, Representative George Nethercutt
Deputy Chief of Staff, Representative Richard Pombo Legislative Director, Representative George Nethercutt
Deputy Chief of Staff, Representative Richard Pombo

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Issues related to the tax treatment of options

Lobbyists:

SHAPIRO, DAVID

Lobbying on the following issues:

INSURANCE FINANCIAL INSTITUTIONS/INVESTMENTS/SECURITIES

Issues related to the regulation of insurance products. H.R. 10 - the Financial CHOICE Act of 2017. Issues related to the risk management of credit unions. H.R.3746 - Business of Insurance Regulatory Reform Act of 2017 and S. 2702 - Business of Insurance Regulatory Reform Act of 2017. Implementation of H.R. 748 - the Coronavirus Aid, Relief, and Economic Security (CARES) Act. Classification of insurance companies as essential during COVID-19 shelter-at-home orders.

Voluntary protection products, including credit insurance, debt protection, debt cancellation and debt suspension agreements, guaranteed asset protection (GAP), and service contracts (SC). All-in APR calculations. December 2017 DoD interpretative rule for the Military Lending Act final rule (MLA Rule) - requesting clarification of the interpretive rule by withdrawing QA #2 as it related to voluntary protection products and their availability for active duty military. H.R.5050 - Veterans and Consumers Fair Credit Act. Implementation of H.R. 748 - the Coronavirus Aid, Relief, and Economic Security (CARES) Act. Classification of financial services companies as essential during COVID-19 shelter-at-home orders.

Lobbyists:

SILVA, ERIC J.
Held the following Government positions
Legislative Aide, Senate EPW Committee and Senator James Jeffords

Harsch, Jonathan J

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE TRUCKING/SHIPPING

Advice and counsel related to trucking industry issues.

Lobbyists:

KUMAR, ROHIT
Held the following Government positions
Dep. Chief of Staff, Senate Republican Leader M. McConnell
Policy Director, Senate Republican Leader W. Frist
General Counsel, Senate Republican Leader T. Lott
Leg. Director, Senator P. Gramm
Dep. Chief Republican Counsel, Senate Banking Cmte Dep. Chief of Staff, Senate Republican Leader M. McConnell
Dep. Chief Republican Counsel, Senate Banking Cmte

METCALF, TODD
Held the following Government positions
â€‹Democratic Chief Tax Counsel, Senate Finance Committee
Tax Counsel, Senator Ron Wyden
Director of Floor Operations / Counsel, Office of Majority Whip
Leg. Director & Tax Counsel, Rep. W. Jefferson
Leg. Director & Counsel, Rep. M. Sandlin Democratic Chief Tax Counsel, Senate Finance Committee
Leg. Director & Counsel, Rep. M. Sandlin

MAYS, JANICE
Held the following Government positions
Democratic Chief Counsel and Staff Director, House Ways and Means Committee â€‹Democratic Chief Counsel and Staff Director, House Ways and Means Committee

PRATER, MARK
Held the following Government positions
Deputy Staff Director, Chief Tax Counsel, Senate Finance Committee â€‹Deputy Staff Director, Chief Tax Counsel, Senate Finance Committee

Lobbying on the following issues:

TRANSPORTATION TAXATION/INTERNAL REVENUE CODE

Advice and counsel related to trucking industry issues.

Lobbyists:

Foreign Entities:

Foreign Entity Name:
Alfa Corporativo S.A. DE CV (Groupo Alfa)
Country :

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Issues related to COVID-19 relief legislation

Lobbyists:

LYON, ANDREW B
Held the following Government positions
â€‹Dep. Asst. Secretary for Tax Analysis, Treasury Department

MCCANDLESS, SCOTT
Held the following Government positions
Tax counsel, Rep. Tim Griffin Tax counsel, Sen. Olympia Snowe

CARLSON, DONALD G
Held the following Government positions
Chief of Staff, Rep. Bill Archer

KUMAR, ROHIT
Held the following Government positions
â€‹â€‹Dep. Chief of Staff, Senate Republican Leader M. McConnell
Policy Director, Senate Republican Leader W. Frist
General Counsel, Senate Republican Leader T. Lott
Leg. Director, Senator P. Gramm
Dep. Chief Republican Counsel, Senate Banking Cmte

METCALF, TODD
Held the following Government positions
â€‹Democratic Chief Tax Counsel, Senate Finance Committee
Tax Counsel, Senator Ron Wyden
Director of Floor Operations / Counsel, Office of Majority Whip
Leg. Director & Tax Counsel, Rep. W. Jefferson
Leg. Director & Counsel, Rep. M. Sandlin

PRATER, MARK
Held the following Government positions
Deputy Staff Director, Chief Tax Counsel, Senate Finance Committee

RUSSO, KARL
Held the following Government positions
Senior Economist, Joint Committee on Taxation

MAYS, JANICE
Held the following Government positions
Democratic Chief Counsel and Staff Director, House Ways and Means Committee

Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE

Strategic advice and advocacy regarding legislation and regulations affecting the alternative investment industry.

Lobbyists:

Foreign Entities:

Foreign Entity Name:
ABC-Mart, Inc.
Country :
JAPAN
Contribution :
$0

Money Spent:

Amount	Client	Government Entities

$840,000

Jul 19, 2019

SECOND QUARTER REPORT

PRICEWATERHOUSECOOPERS